J Spiess

Author PubWeight™ 121.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981 9.64
2 Molecular characterization and chromosomal mapping of melanoma growth stimulatory activity, a growth factor structurally related to beta-thromboglobulin. EMBO J 1988 3.26
3 Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour. Nature 1982 2.44
4 Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986 2.29
5 Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2. J Neurosci 1999 2.20
6 Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2. Nat Genet 2000 1.90
7 Chemical and biological characterization of corticotropin releasing factor. Recent Prog Horm Res 1983 1.86
8 Primary structure of corticotropin-releasing factor from ovine hypothalamus. Proc Natl Acad Sci U S A 1981 1.78
9 Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA. Proc Natl Acad Sci U S A 1988 1.70
10 Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982 1.58
11 Characterization of rat hypothalamic corticotropin-releasing factor. Proc Natl Acad Sci U S A 1983 1.58
12 Strain and substrain differences in context- and tone-dependent fear conditioning of inbred mice. Behav Brain Res 1999 1.53
13 Relationship between fos production and classical fear conditioning: effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J Neurosci 1998 1.49
14 Production of an epidermal growth factor receptor-related protein. Science 1984 1.46
15 Phosphorylated cAMP response element binding protein in the mouse brain after fear conditioning: relationship to Fos production. Brain Res Mol Brain Res 2001 1.37
16 Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides. Proc Natl Acad Sci U S A 1987 1.37
17 Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus. Biochemistry 1981 1.35
18 Production of the Fos protein after contextual fear conditioning of C57BL/6N mice. Brain Res 1998 1.34
19 Isolation and characterization of somatostatin from pigeon pancreas. Proc Natl Acad Sci U S A 1979 1.34
20 In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, beta-endorphin, and corticosterone. Endocrinology 1982 1.32
21 Purification and partial characterization of inhibin from porcine follicular fluid. Biochem Biophys Res Commun 1985 1.27
22 Characterization of a teleost gonadotropin-releasing hormone. Proc Natl Acad Sci U S A 1983 1.26
23 Characterization of rat hypothalamic growth hormone-releasing factor. Nature 1983 1.24
24 Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30. Proc Natl Acad Sci U S A 1998 1.23
25 Human pancreatic growth-hormone-releasing factor selectively stimulates growth-hormone secretion in man. Lancet 1983 1.23
26 Evidence for the existence of a biosynthetic precursor for somatostatin. Diabetes 1979 1.22
27 Generalization of fear responses in C57BL/6N mice subjected to one-trial foreground contextual fear conditioning. Behav Brain Res 1998 1.19
28 Corticotropin-releasing factor (CRF): central effects on mean arterial pressure and heart rate in rats. Endocrinology 1982 1.19
29 Inhibin A-subunit cDNAs from porcine ovary and human placenta. Proc Natl Acad Sci U S A 1986 1.16
30 Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest 1983 1.14
31 Stress-induced alternative splicing of acetylcholinesterase results in enhanced fear memory and long-term potentiation. Mol Psychiatry 2004 1.08
32 Phosphorylation of high mobility group protein 14 by casein kinase II. J Biol Chem 1985 1.07
33 Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption. Life Sci 1982 1.03
34 Effect of tone-dependent fear conditioning on heart rate and behavior of C57BL/6N mice. Behav Neurosci 1997 1.03
35 Differential impairment of auditory and contextual fear conditioning by protein synthesis inhibition in C57BL/6N mice. Behav Neurosci 1999 1.01
36 Identification of amino acids in the N-terminal domain of corticotropin-releasing factor receptor 1 that are important determinants of high-affinity ligand binding. J Neurochem 1999 1.01
37 Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology 1983 1.01
38 Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism. J Neurosci Res 1996 0.99
39 Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry 1980 0.98
40 Characterization of native corticotropin-releasing factor receptor type 1 (CRFR1) in the rat and mouse central nervous system. J Neurosci Res 1998 0.98
41 The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses. Proc Natl Acad Sci U S A 1997 0.96
42 Primary structure and functional expression of a glutaminyl cyclase. Proc Natl Acad Sci U S A 1991 0.96
43 Post-training injections of catecholaminergic drugs do not modulate fear conditioning in rats and mice. Neurosci Lett 2001 0.95
44 Investigation of larger forms of somatostatin in pigeon pancreas and rat brain. Metabolism 1978 0.95
45 Pharmacology and biology of corticotropin-releasing factor (CRF) receptors. Receptors Channels 2002 0.95
46 Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice. J Neurosci 2000 0.95
47 Pituitary microadenomas causing Cushing's disease respond to corticotropin-releasing factor. J Clin Endocrinol Metab 1982 0.94
48 Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Regul Pept 1982 0.93
49 Sequence analysis of a growth hormone releasing factor from a human pancreatic islet tumor. Biochemistry 1982 0.93
50 Isolation and characterization of somatostatin from anglerfish pancreatic islet. Endocrinology 1979 0.93
51 Primary structure and tissue distribution of anglerfish carboxypeptidase H. Mol Cell Endocrinol 1991 0.93
52 Inhibition of corticotropin releasing hormone type-1 receptor translation by an upstream AUG triplet in the 5' untranslated region. Mol Pharmacol 2001 0.92
53 Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1. Protein Sci 2001 0.91
54 Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995 0.91
55 Evidence fore biosynthesis and differential post-translational proteolytic processing of different (pre)prosomatostatins in pancreatic islets. J Biol Chem 1983 0.91
56 Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs. Peptides 2001 0.89
57 Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments. Neuropharmacology 2001 0.89
58 The anglerfish somatostatin-28-generating propeptide converting enzyme is an aspartyl protease. Endocrinology 1991 0.89
59 A synthetic glucagon-like peptide-1 analog with improved plasma stability. J Endocrinol 1998 0.89
60 Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor. Brain Res Mol Brain Res 1997 0.89
61 Phosphorylation of high mobility group 14 protein by cyclic nucleotide-dependent protein kinases. J Biol Chem 1982 0.89
62 Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 1983 0.89
63 Synthesis and characterization of a photoactivatable analog of corticotropin-releasing factor for specific receptor labeling. Proc Natl Acad Sci U S A 1996 0.88
64 Actions of CRF and its analogs. Curr Med Chem 1999 0.88
65 Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. Eur J Biochem 1998 0.88
66 Cloning and structure of the gene encoding the human N-methyl-D-aspartate receptor (NMDAR1). Gene 1995 0.87
67 Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice. Neuroscience 2005 0.87
68 Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract. Allergy 1979 0.87
69 Sequence analysis of rat hypothalamic corticotropin-releasing factor with the o-phthalaldehyde strategy. Biochemistry 1983 0.87
70 A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists. Proc Natl Acad Sci U S A 2001 0.87
71 Identification of a somatostatin-14-generating propeptide converting enzyme as a member of the kex2/furin/PC family. Endocrinology 1991 0.86
72 Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: unusual pharmacology of the type 1 receptor. J Neurochem 1997 0.85
73 Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: implications for the ligand-binding site. Proc Natl Acad Sci U S A 1998 0.85
74 Mechanism of action of somatostatin: an overview of receptor function and studies of the molecular characterization and purification of somatostatin receptor proteins. Metabolism 1990 0.84
75 Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system. Mol Psychiatry 2008 0.84
76 Structural heterogeneity of the alpha subunits of the nicotinic acetylcholine receptor in relation to agonist affinity alkylation and antagonist binding. Biochemistry 1986 0.84
77 Corticotropin-releasing factor (CRF) and the urocortins differentially regulate catecholamine secretion in human and rat adrenals, in a CRF receptor type-specific manner. Endocrinology 2006 0.84
78 Comparison of prohormone-processing activities in islet microsomes and secretory granules: evidence for distinct converting enzymes for separate islet prosomatostatins. J Cell Biol 1984 0.84
79 Regulation of corticotropin-releasing factor receptor function in human Y-79 retinoblastoma cells: rapid and reversible homologous desensitization but prolonged recovery. J Neurochem 1997 0.83
80 Corticotropin-releasing factor receptor 1 in mouse spleen: expression after immune stimulation and identification of receptor-bearing cells. J Immunol 1999 0.83
81 Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav Brain Res 2000 0.83
82 Role of regional neurotransmitter receptors in corticotropin-releasing factor (CRF)-mediated modulation of fear conditioning. Neuropharmacology 2000 0.83
83 [Lambl's excrescence and cerebral ischemic insult]. Nervenarzt 2006 0.82
84 Modulation of the inflammatory response by corticotropin-releasing factor. Eur J Pharmacol 1997 0.81
85 Effect of 17-beta estradiol on pre-existing atherosclerotic lesions: role of the endothelium. Atherosclerosis 1999 0.81
86 High-performance liquid chromatographic purification of peptide hormones: ovine hypothalamic amunine (corticotropin releasing factor). Anal Biochem 1982 0.81
87 NH2-terminal amino acid sequence and peptide mapping of purified human beta-lipotropin: comparison with previously proposed sequences. Proc Natl Acad Sci U S A 1982 0.81
88 Chronic morphine treatment alters NMDA receptor-mediated synaptic transmission in the nucleus accumbens. J Neurosci 1999 0.81
89 Electrospray ionization mass spectrometry of biotin binding to streptavidin. J Am Soc Mass Spectrom 1995 0.80
90 Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA. DNA Cell Biol 1993 0.80
91 Characterization of neurophysin in the anterior pituitary gland of sheep. Neuroendocrinology 1988 0.79
92 Modulation of hypothalamic NMDA receptor function by cyclic AMP-dependent protein kinase and phosphatases. J Neurochem 2000 0.79
93 Serological investigations in hymenoptera sting allergy: IgE and haemagglutinating antibodies against bee venom in patients with bee sting allergy, bee keepers and non-allergic blood donors. Clin Allergy 1977 0.78
94 Cotranslational and posttranslational proteolytic processing of preprosomatostatin-I in intact islet tissue. J Cell Biol 1986 0.78
95 Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning. Neuroscience 2009 0.78
96 Neuropathy and hyperthyroidism. Electroencephalogr Clin Neurophysiol 1969 0.77
97 Thyrotropin-releasing hormone (TRH) precursor processing. Characterization of mature TRH and non-TRH peptides synthesized by transfected mammalian cells. J Biol Chem 1989 0.77
98 CRF and CRF receptors. Results Probl Cell Differ 1999 0.77
99 The role of the fourth extracellular domain of the rat corticotropin-releasing factor receptor type 1 in ligand binding. Eur J Biochem 1999 0.77
100 Immunomodulatory role of the corticotropin-releasing factor. Arch Immunol Ther Exp (Warsz) 2001 0.77
101 NS-257, a novel competitive AMPA receptor antagonist, interacts with kainate and NMDA receptors. Brain Res 1999 0.76
102 The effect of acute immobilization stress on the abundance of corticotropin-releasing factor receptor in lymphoid organs. J Neuroimmunol 2000 0.76
103 Overexpression of a functional NMDA receptor subunit (NMDAR1) in baculovirus-infected Trichoplusia ni insect cells. Brain Res Mol Brain Res 1996 0.76
104 In vivo NMDA/dopamine interaction resulting in Fos production in the limbic system and basal ganglia of the mouse brain. Brain Res Mol Brain Res 2000 0.76
105 Isolation and characterization of hypothalamic growth-hormone releasing factor from common carp, Cyprinus carpio. Neuroendocrinology 1992 0.76
106 Characterization of the NR1, NR2A, and NR2C receptor proteins. Protein Sci 1993 0.75
107 Processing of an anglerfish somatostatin precursor to a hydroxylysine-containing somatostatin 28. Proc Natl Acad Sci U S A 1985 0.75
108 Anglerfish pancreatic islets produce two forms of somatostatin-28. Adv Exp Med Biol 1985 0.75
109 Treatment strategies of age-related memory dysfunction by modulation of neuronal plasticity. Mini Rev Med Chem 2007 0.75
110 Isoproterenol enhances a calcium-independent potassium current in mouse anterior pituitary tumor cells. J Neurophysiol 1992 0.75
111 Post-translational processing of anglerfish islet somatostatin precursors. Adv Exp Med Biol 1985 0.75
112 Histamine slows the onset of desensitization of rat cortical NMDA receptors. Neuroreport 1996 0.75
113 Improved method for identification of proteins using two-dimensional electrophoresis with immobilized pH gradient isoelectric focusing. Electrophoresis 1991 0.75
114 [Choice of the therapeutic schedule of cotrimoxazole in urinary tract infections; comparison of the effect with this of trimethoprim alone (author's transl)]. Schweiz Rundsch Med Prax 1977 0.75
115 [Serologic-nephelometric method for the detection of allergic reactions to small-molecular drugs using polystyrene sodium particles instead of soluble polystyrene sulfonate sodium as pharmaceutic aids]. Schweiz Med Wochenschr 1977 0.75
116 [Significance of serological studies in the diagnosis and therapy of insect-sting allergy]. Schweiz Med Wochenschr 1977 0.75
117 Purification of prosomatostatin-converting enzymes. Metabolism 1990 0.75
118 [Influence of unsaturated long-chain compounds on kink formation in membrane models]. Z Naturforsch B 1972 0.75
119 Isolation and sequence analysis of oxytocin from the sheep corpus luteum. Neuropeptides 1986 0.75
120 Value of the proximal flow convergence method for quantification of the regurgitant volume in mitral regurgitation Influence of the mechanism of regurgitation, the imaging of the flow convergence region, and different calculation modalities. Z Kardiol 2004 0.75